VXL:TSXV, Vaxil Bio Ltd.

VXL stock overview

Vaxil Bio Ltd. (VXL:TSXV) closed at $0.110 on November 6, 2026, unchanged on the day. The stock trades 62.1% below its 52-week high of $0.290 and 10.0% above its 52-week low of $0.100. Over the past year, it lost 33.3%. Vaxil Bio Ltd. is part of the Life Sciences sector (Pharmaceuticals).

Key figures

Price
$0.110
Day change
0.00%
Volume
1,522
Average volume
1,480
Market cap
438K+
52-week range
$0.100 – $0.290
50-day average
$0.142
200-day average
$0.170

Price action over the past year

In 252 trading sessions since November 6, 2025, VXL closed higher on 18 days (7%). Its best day was April 21, 2026 (+46.43%) and its worst was October 28, 2026 (-23.08%). The stock moved 10% or more in a single session 11 times. It opened at least 5% above the previous day's high 7 times.

Recent signals

About Vaxil Bio Ltd.

Vaxil Bio Ltd is a biotechnology company engaged in developing therapies for cancer treatment.

Similar stocks

Find more stocks like VXL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.